We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Vols saber com serà la teva estada a l’Hospital Universitari Vall d’Hebron? Aquí trobaràs tota la informació.
Speaker: Dr. María Alieva, research group at the Sols-Morreale Biomedical Research Institute (CSIC-UAM)
By offering spatial, molecular, and morphological data over time, live-cell imaging provides a deeper comprehension of cellular and signaling events pivotal in cancer-related processes, such as tumor heterogeneity, treatment response, and tumor invasion. This dynamic cellular response holds promise in refining clinical outcomes by pinpointing biomarkers or actionable targets to enhance therapeutic effectiveness. Nevertheless, live imaging of intricate systems, like co-culture assays or intravital microscopy and organotypic brain slices, generates big and complex datasets, necessitating tailored analytical pipelines to interpret the vast amount of dynamic features captured. Dr. Alieva's group, imAIgene lab, specializes in computational approaches for dynamic imaging analysis. Their focus lies in gaining insights into various aspects of cancer biology, including cellular immunotherapy mode-of-action against tumors, tumor heterogeneity in treatment response, and tumor invasion. In this seminar, Dr. Alieva will highlight several recent research applications that offer biological insights into these topics. These applications encompass a range of techniques, from single-cell dynamic classification and dynamic cellular interactome analysis to the utilization of organoid models for studying intratumor heterogeneity. Additionally, the lab employs multi-omics approaches that integrate imaging with single-cell transcriptomic information, to leverage the results from dynamic imaging assays to improve therapeutic efficacy and facilitate biomarker discovery.
Host: Dr. Juan Ángel Recio, Head of group Biomedical Research in Melanoma (VHIR)
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.